Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207935 · ClinicalTrials.gov registry record · Phase 4
Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
A Phase 4 study, sponsored by Children's National Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00207935 is a Phase 4 study that has completed, run by Children's National Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT00207935, a Phase 4 study, has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being done to see if children with learning problems can learn how to swallow pills without chewing them. The reason this is important is that if a person has seizures, medications must be taken every day. Most medications need to be taken 2 or 3 times per day. Some medications have slow release and only are taaken once per day. Medications with slow release usually come in capsule form and cannot be opened or chewed. This study investiates whether children with developmental delay can be taught how to swalow pills.
Interventions
- BEHAVIORAL Swallow instruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00207935
The ClinicalTrials.gov registry entry for NCT00207935 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Swallow instruction is the first listed.
NCT00207935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00207935 about?
NCT00207935 is a clinical study titled "Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population". This study is being done to see if children with learning problems can learn how to swallow pills without chewing them. The reason this is important is that if a person has seizures, medications must be taken every day. Most medications need to be taken 2 or 3 times per day. Some medications have sl...
What is the current status of trial NCT00207935?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-08. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00207935?
The interventions under investigation include: Swallow instruction (BEHAVIORAL).
Who is sponsoring clinical trial NCT00207935?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.